Karkinos Healthcare

Executive Summary

Karkinos Healthcare Pvt. Ltd., a subsidiary of Reliance Industries, is pioneering a technology-led, end-to-end oncology platform in India. Founded in 2020, the company leverages a distributed hub-and-spoke model, integrating hospitals, advanced molecular diagnostic labs, and digital health services to deliver comprehensive cancer care. Its proprietary knowledge platform enables early detection screening, personalized diagnostics, treatment coordination, and patient support, significantly improving access and affordability across the country. By addressing critical gaps in oncology infrastructure and leveraging Reliance's deep resources, Karkinos is poised to scale its impact rapidly. The platform has already screened thousands of patients and is expanding its network into tier 2 and tier 3 cities, where cancer care access is severely limited. With the Indian cancer burden growing at 1.1 million new cases annually, Karkinos offers a scalable solution that combines clinical excellence with technological innovation, positioning itself as a key player in India's healthcare transformation.

Upcoming Catalysts (preview)

• Q4 2026Expansion of hub-and-spoke network to 10 new cities in underserved regions70% success
• Q1 2027Strategic partnership with Ayushman Bharat or state health insurance schemes for population-level screening60% success
• Mid 2027Launch of AI-driven early detection algorithm for common cancers (lung, breast) integrated into the platform50% success